Literature DB >> 18578476

Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.

Francesco Gentili1, Claudia Cardinaletti, Cristian Vesprini, Antonio Carrieri, Francesca Ghelfi, Aniket Farande, Mario Giannella, Alessandro Piergentili, Wilma Quaglia, Jonne M Laurila, Anna Huhtinen, Mika Scheinin, Maria Pigini.   

Abstract

The goal of the present study was to modulate the receptor interaction properties of known alpha 2-adrenoreceptor (AR) antagonists to obtain novel alpha 2-AR agonists with desirable subtype selectivity. Therefore, a phenyl group or one of its bioisosteres or aliphatic moieties with similar steric hindrance were introduced into the aromatic ring of the antagonist lead basic structure. The functional properties of the novel compounds allowed our previous observations to be confirmed. The high efficacy of 7, 12, and 13 as alpha 2-AR agonists and the significant alpha 2C-AR subtype selective activation displayed by 11 and 15 demonstrated that favorable interactions to induce alpha 2-AR activation were formed between the pendant groups of the ligands and the aromatic cluster present in transmembrane domain 6 of the binding site cavity of the receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18578476     DOI: 10.1021/jm800250z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.

Authors:  Fabio Del Bello; Valentina Bargelli; Carlo Cifani; Paola Gratteri; Carla Bazzicalupi; Eleonora Diamanti; Mario Giannella; Valerio Mammoli; Rosanna Matucci; Maria Vittoria Micioni Di Bonaventura; Alessandro Piergentili; Wilma Quaglia; Maria Pigini
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

2.  Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction.

Authors:  Maria Elena Giusepponi; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura; Laura Mattioli; Alan Hudson; Eleonora Diamanti; Fabio Del Bello; Mario Giannella; Valerio Mammoli; Corinne Dalila Paoletti; Alessandro Piergentili; Maria Pigini; Wilma Quaglia
Journal:  ACS Med Chem Lett       Date:  2016-09-08       Impact factor: 4.345

3.  Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility.

Authors:  Zoltán S Zádori; Ágnes Fehér; Viktória E Tóth; Mahmoud Al-Khrasani; László Köles; Szabina Sipos; Fabio Del Bello; Maria Pigini; Klára Gyires
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.